References
- 1Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J. 2002; 78: 63–70. DOI: 10.1136/pmj.78.916.63
- 2Valente M, Del Negro I, Bagatto D, Garbo R, Lettieri C, Bernardini A, et al. Clinical and magnetic resonance study of a case of subacute sclerosing panencephalitis treated with ketogenic diet. BMJ Neurol Open. 2021; 3:
e000176 . DOI: 10.1136/bmjno-2021-000176 - 3Sonoda Y, Sonoda M, Yonemoto K, Sanefuji M, Taira R, Motomura Y, et al. Favorable outcomes of interferon-α and ribavirin treatment for a male with subacute sclerosing panencephalitis. J Neuroimmunol. 2021; 358:
577656 . DOI: 10.1016/j.jneuroim.2021.577656 - 4Nathan J, Khedekar Kale D, Naik VD, Thakker F, Bailur S. Substantial Remission in Subacute Sclerosing Panencephalitis by Following the Ketogenic Diet: A Case Report. Cureus. 2019; 11:
e5485 . DOI: 10.7759/cureus.5485 - 5Kwak M, Yeh HR, Yum MS, Kim HJ, You SJ, Ko TS. A long-term subacute sclerosing panencephalitis survivor treated with intraventricular interferon-alpha for 13 years. Korean J Pediatr. 2019; 62: 108–112. DOI: 10.3345/kjp.2018.06730
- 6Eroglu E, Gokcil Z, Bek S, Ulas UH, Ozdag MF, Odabasi Z. Long-term follow-up of patients with adult-onset subacute sclerosing panencephalitis. J Neurol Sci. 2008; 275: 113–6. DOI: 10.1016/j.jns.2008.07.033
- 7Prashanth LK, Taly AB, Ravi V, Sinha S, Rao S. Long-term survival in subacute sclerosing panencephalitis: an enigma. Brain Dev. 2006; 28: 447–52. DOI: 10.1016/j.braindev.2006.01.008
- 8Miyazaki M, Nishimura M, Toda Y, Saijo T, Mori K, Kuroda Y. Long-term follow-up of a patient with subacute sclerosing panencephalitis successfully treated with intrathecal interferon alpha. Brain Dev. 2005; 27: 301–3. DOI: 10.1016/j.braindev.2004.07.003
- 9Kurata T, Matsubara E, Yokoyama M, Nagano I, Shoji M, Abe K. Improvement of SSPE by intrathecal infusion of alpha-IFN. Neurology. 2004; 63: 398–9. DOI: 10.1212/01.WNL.0000130516.54312.A1
- 10Risk WS, Risk WS 2nd. Subacute sclerosing panencephalitis with remission in a Bosnian refugee child. Pediatr Infect Dis J. 2003; 22: 757–8. DOI: 10.1097/01.inf.0000081585.84685.09
- 11Yazaki M, Yamazaki M, Urasawa N, Morita H, Ikeda S. Successful treatment with alpha-interferon of a patient with chronic measles infection of the brain and parkinsonism. Eur Neurol. 2000; 44: 184–6. DOI: 10.1159/000008232
- 12Santoshkumar B, Radhakrishnan K. Substantial spontaneous long-term remission in subacute sclerosing panencephalitis (SSPE). J Neurol Sci. 1998; 154: 83–8. DOI: 10.1016/S0022-510X(97)00303-1
- 13Woelfle J, Haverkamp F, Albert F. Long-term survival and temporary clinical improvement in subacute sclerosing panencephalitis. Pediatr Neurol. 1996; 15:
83 . DOI: 10.1016/0887-8994(96)00165-8 - 14Barraclough CR. Long-term survival of a case of subacute sclerosing panencephalitis. J Neurol Neurosurg Psychiatry. 1983; 46: 457–8. DOI: 10.1136/jnnp.46.5.457
- 15Risk WS, Haddad FS, Chemali R. Substantial spontaneous long-term improvement in subacute sclerosing panencephalitis. Six cases from the Middle East and a review of the literature. Arch Neurol. 1978; 35: 494–502. DOI: 10.1001/archneur.1978.00500320014004
- 16Yalaz K, Anlar B, Oktem F, Aysun S, Ustacelebi S, Gurcay O, et al. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology. 1992; 42: 488–91. DOI: 10.1212/WNL.42.3.488
- 17Anlar B, Yalaz K, Oktem F, Köse G. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology. 1997; 48: 526–8. DOI: 10.1212/WNL.48.2.526
- 18Anlar B, Aydin OF, Guven A, Sonmez FM, Kose G, Herguner O. Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis. Clin Ther. 2004; 26: 1890–4. DOI: 10.1016/j.clinthera.2004.11.002
- 19Gascon GG; International Consortium on Subacute Sclerosing Panencephalitis. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study. J Child Neurol. 2003; 18: 819–27. DOI: 10.1177/088307380301801201